Clinical trials
Diabetes clinical trials
Below are recruiting diabetes clinical trials, each written for real people, not researchers. We’re tracking 2,136 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04011020RecruitingPhase 3
Stem cell treatment for type 1 diabetes
This study tests a treatment that uses a patient's own immune cells to help the body make more insulin. It may help people with type 1 diabetes manage their blood sugar better.
Paramus, New JerseyAges 10 years+ - NCT07867080RecruitingPhase 3
Gene therapy injection for diabetic macular edema
This trial tests a one-time gene therapy injection into the eye for adults with diabetic macular edema (DME), a condition where fluid builds up in the retina and blurs vision. The goal is to reduce the need for frequent eye injections and help maintain vision over time.
Scottsdale, ArizonaAges 18 years+ - NCT06269419Recruiting
Diabetes eye disease natural progression study
This study follows people with type 2 diabetes to understand how diabetic retinopathy (an eye disease caused by diabetes) changes over time without treatment. It may help if you have no other eye issues causing new blood vessels and are not planning for certain eye procedures.
Chengdu, SichuanAges 18–75 - NCT06320600Recruiting
Precision Diabetes Medicine Program in China
This study is looking for people who have been recently diagnosed with diabetes (within the past year) to help find the best treatments for each person's unique needs. It is part of a national program in China to personalize diabetes care.
Changsha, HunanAges Any age - NCT05759676Recruiting
Diabetes and a new drug-free heart stent after angioplasty
This trial tests whether a polymer-free amphilimus-eluting stent is safe and works well for people with diabetes after a recent heart blockage procedure. It may help improve how well the artery stays open, while tracking side effects over time.
SeoulAges 19 years+ - NCT05572502Recruiting
Online program for type 2 diabetes reversal goals
This trial studies an online program designed to help people with type 2 diabetes improve their health and diabetes control. You may be able to join if you already have type 2 diabetes and can follow the study plan and your current medication routine.
Washington D.C., District of ColumbiaAges 18 years+ - NCT05584293Recruiting
Diabetes registry for adults with diabetes in hospital care
This study sets up a diabetes registry, which means collecting information about people’s diabetes care in a hospital clinic. It may help improve understanding of how diabetes is managed in real life, which can support better future care.
Almelo, OverijsselAges 18 years+ - NCT05132179Recruiting
Testing two antiseptic creams for diabetic foot ulcers
This study compares two topical (applied on the skin) antimicrobial agents—Dakin’s and Prontosan—to help heal diabetic foot ulcers. You may be eligible if you have a diabetic foot ulcer that has been present for at least 3 weeks and is large enough.
Uddevalla, TrollhattanAges 18–100 - NCT06412224RecruitingEarly Phase 1
Testing a new drug for diabetic eye disease after vitrectomy
This trial tests a new medicine, RRG001, given after vitrectomy surgery for severe diabetic eye disease. It aims to see if the drug is safe and helps prevent vision loss.
TianjinAges 20–80 - NCT07852988RecruitingPhase 4
Adding digestive enzymes to usual diabetes treatment
This study tests adding a digestive enzyme (pancreatin) to your usual diabetes medicines to see if it helps control blood sugar better. You may benefit if your current treatment is working, but your A1C is still not in the target range.
Zabrze, Silesian VoivodeshipAges 35–75 - NCT07851753Recruiting
Lumbopelvic stability in gestational diabetes during pregnancy
This study looks at how well the muscles in your lower back and pelvis work in pregnant women with and without gestational diabetes. It uses simple movement tests to compare stability and may help improve care for future pregnancies.
Lahore, Punjab ProvinceAges 20–40 - NCT07843485RecruitingPhase 3
Weight loss medication for adults with type 2 diabetes
This study tests a new medicine called petrelintide to help people with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be an option if you've struggled with weight loss through diet alone.
Los Angeles, CaliforniaAges 18 years+ - NCT05780905RecruitingPhase 4
Semaglutide study for brain blood flow in type 2 diabetes
This trial tests whether semaglutide changes blood flow in the brain and the brain’s “barrier” (how well the brain is protected) in people with type 2 diabetes. It may help researchers understand brain-related effects of diabetes treatment using scans and blood tests.
Seattle, WashingtonAges 40–65 - NCT06444074Recruiting
PACT: Conversations to help manage diabetes
This study tests a program called 'PACT' that uses conversations to help you manage your diabetes. It is for people with type 2 diabetes whose blood sugar is not well controlled and who are part of the NHGP Teamlets program.
SingaporeAges 21–64 - NCT07835360Recruiting
Body changes after starting GLP-1 medications for weight or diabetes
This study looks at how your body composition (muscle and fat) changes after you start a GLP-1 medication for obesity or type 2 diabetes. You will be followed for a year with body scans to see the effects.
Mexico City, Mexico CityAges 18 years+ - NCT07837934RecruitingPhase 2
Colchicine to prevent heart disease in adults with type 2 diabetes
This trial tests whether a daily low-dose of colchicine, a common anti-inflammatory medicine, can help prevent heart attacks and strokes in people with type 2 diabetes who do not yet have heart disease. If it works, it could be a simple addition to your current diabetes care.
Singapore, SingaporeAges 21–80 - NCT07835724Recruiting
Understanding what causes type 1 diabetes
This study looks at how things in the environment might affect the risk of type 1 diabetes. It aims to find out what triggers the disease, which could help with prevention and treatment.
Changsha, HunanAges 3–70 - NCT07831798RecruitingPhase 1/Phase 2
Gene therapy for type 1 diabetes
This study tests a new gene therapy (VV-14300) that aims to help people with type 1 diabetes make insulin again. It might improve blood sugar control and reduce the need for insulin.
TorontoAges 18–65 - NCT07829302RecruitingPhase 1/Phase 2
Gene therapy for type 1 diabetes
This trial tests an investigational gene therapy that may help people with type 1 diabetes produce some insulin on their own, potentially reducing the amount of insulin they need. It is an early-stage study, so participants will be closely monitored for safety and any changes in their diabetes control.
MelbourneAges 18–65 - NCT07827417Recruiting
Balance training for diabetic nerve pain
This study compares two types of exercise to help improve balance in people with diabetic peripheral neuropathy. You may join if you have diabetes-related nerve damage and trouble with balance.
IslamabadAges 40 years+ - NCT07830082Recruiting
Drawing and writing activities for teens with type 1 diabetes
This study tests whether drawing and writing activities can help teenagers with type 1 diabetes manage their condition. It may improve their emotional well-being and diabetes control.
Ankara, AnkaraAges 9–18 - NCT07827625Recruiting
Comparing two physical therapies for ankle pain in type 2 diabetes
This study tests whether a specific hands-on therapy (Mulligan mobilization) improves ankle motion, pain, and quality of life better than standard physical therapy in people with type 2 diabetes who have ankle stiffness and pain.
Islamabad, FederalAges 50–70 - NCT07820371Recruiting
Perfusion index for diabetic ketoacidosis severity in the emergency department
This study looks at a simple, non-invasive measurement called the perfusion index, which shows how well blood is flowing to your tissues, to help doctors quickly determine how severe diabetic ketoacidosis (a serious diabetes complication) is. The goal is to see if this measurement can guide treatment and improve outcomes.
Ankara, AnkaraAges 18 years+ - NCT07822152RecruitingPhase 1
Cord blood stem cells for diabetic kidney disease
This trial tests whether injecting stem cells from donated umbilical cords can help people with kidney damage caused by type 2 diabetes. The goal is to see if this treatment can slow the decline in kidney function and safely improve their condition.
WuhanAges 30–70
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes?
- Yes. Clin2 currently lists 2,136 recruiting diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.